Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 18.70
+0.05 (0.27%)
Oct 27, 2026, 4:10 PM AEDT
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.37 billion as of October 27, 2026. It is the 7,401st most valuable company in the world and the 132nd biggest in Australia. Its market cap has decreased by 12.42% in one year.
Market Cap
2.37B
Enterprise Value
2.08B
Revenue
69.53M
Global Rank
Country Rank
#132 Australia
PE Ratio
119.94
ChartMarket Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 2.37B, an increase of 11,228.54%. That is a compound annual growth rate of 24.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 2.37B | 0.59% |
| Dec 31, 2025 | 2.36B | 48.44% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.35B |
| Mesoblast | 2.41B |
| PYC Therapeutics | 1.89B |
| Clarity Pharmaceuticals | 578.28M |
| Clinuvel Pharmaceuticals | 363.08M |
| Racura Oncology | 300.97M |
| Tetratherix | 284.13M |
| BLS Pharmaceuticals | 230.30M |